XML 54 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
12 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table presents revenue for each reportable segment and Corporate:
(in millions)202320222021
Pharmaceutical$190,009 $165,491 $145,796 
Medical15,014 15,887 16,687 
Total segment revenue205,023 181,378 162,483 
Corporate (1)(11)(14)(16)
Total revenue$205,012 $181,364 $162,467 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:
(in millions)202320222021
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1)$188,812 $164,580 $144,988 
Nuclear and Precision Health Solutions (2)1,197 911 808 
Pharmaceutical segment revenue
190,009 165,491 145,796 
Medical Products and Distribution (3)12,374 13,462 14,485 
Cardinal Health at-Home Solutions2,640 2,425 2,202 
Medical segment revenue
15,014 15,887 16,687 
  Total segment revenue205,023 181,378 162,483 
Corporate (4)(11)(14)(16)
Total revenue$205,012 $181,364 $162,467 
(1)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(2)Increase from prior year relates to new product launches and changes in revenue presentation from agent to principal for certain customer contracts.
(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.
(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
(in millions)202320222021
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1)$188,812 $164,580 $144,988 
Nuclear and Precision Health Solutions (2)1,197 911 808 
Pharmaceutical segment revenue
190,009 165,491 145,796 
Medical Products and Distribution (3)12,374 13,462 14,485 
Cardinal Health at-Home Solutions2,640 2,425 2,202 
Medical segment revenue
15,014 15,887 16,687 
  Total segment revenue205,023 181,378 162,483 
Corporate (4)(11)(14)(16)
Total revenue$205,012 $181,364 $162,467 
(1)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(2)Increase from prior year relates to new product launches and changes in revenue presentation from agent to principal for certain customer contracts.
(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.
(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)202320222021
United States$200,384 $176,855 $157,756 
International4,639 4,523 4,727 
Total segment revenue205,023 181,378 162,483 
Corporate (1)(11)(14)(16)
Total revenue$205,012 $181,364 $162,467 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
(in millions)202320222021
Pharmaceutical$1,999 $1,770 $1,684 
Medical111 216 577 
Total segment profit2,110 1,986 2,261 
Corporate(1,383)(2,582)(1,789)
Total operating earnings/(loss)$727 $(596)$472 
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:
(in millions)202320222021
Pharmaceutical$225 $193 $151 
Medical213 216 226 
Corporate254 283 406 
Total depreciation and amortization$692 $692 $783 

(in millions)202320222021
Pharmaceutical$90 $79 $55 
Medical209 140 97 
Corporate182 168 248 
Total additions to property and equipment$481 $387 $400 
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)202320222021
Pharmaceutical$28,077 $26,409 $23,624 
Medical (1) (2)10,130 11,632 15,408 
Corporate5,210 5,837 5,421 
Total assets$43,417 $43,878 $44,453 
(1)Assets of $1.1 billion related to the Cordis business were included within Medical at June 30, 2021. We sold the Cordis business during fiscal 2022.
(2)Medical reflects $1.2 billion and $2.1 billion cumulative pre-tax goodwill impairment charges recorded in connection with the goodwill impairment testing for the Medical Unit during fiscal 2023 and 2022, respectively.
Property and Equipment, Net by Geographic Area
The following table presents property and equipment, net by geographic area:
(in millions)202320222021
United States$2,026 $1,976 $1,958 
International436 385 402 
Property and equipment, net$2,462 $2,361 $2,360